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Abstract
Non-communicable disease diagnosis frequently relies on biochemical measurements but
laboratory infrastructure in low-income settings is often insufficient and distances to clinics
may be vast. We present a model for point of care (POC) epidemiology as used in our
study of chronic disease in the Haiti Health Study, in rural and urban Haiti. Point of care test-
ing (POCT) of creatinine, cholesterol, and hemoglobin A1c as well as physical measurements
of weight, height, and waist circumference allowed for diagnosis of diabetes, chronic kidney
disease, dyslipidemias, and obesity. Methods and troubleshooting techniques for the data
collection of this study are presented. We discuss our method of community-health worker
(CHW) training, community engagement, study design, and field data collection. We also
discuss the machines used and our quality control across CHWs and across geographical
regions. Pitfalls tended to include equipment malfunction, transportation issues, and cultural
differences. May this paper provide information for those attempting to perform similar
diagnostic and screening studies using POCT in resource poor settings.
Introduction
Non-communicable disease (NCD) are the leading cause of death worldwide [1] and cardio-
vascular disease is the leading cause of death and disability-adjusted life years lost in low-and
middle-income countries. In the Caribbean, chronic diseases are now the leading cause of pre-
mature mortality, accounting for nearly half of all deaths of persons under 70 years, and for
two out of three deaths overall [2]. Therefore, proper measurement of these biochemical mea-
surements in defining disease prevalence is necessary. Point of care testing (POCT) offers an
avenue for screening in resource-limited settings.
NCD diagnosis frequently relies on biochemical measurements. The infrastructure required
for biochemical testing is unavailable in many regions, especially in low-income countries. In
high-resource settings, blood tests are sent to laboratories where cooling and specific storage
requirements are in place; they also have reporting systems to central databases that often
require internet connection, as well as trained individuals to draw blood, monitor quality,
and report results. Testing storage during transport may be economically too difficult if dis-
tances are far and hard to traverse. Laboratories themselves may lack electricity, refrigeration,
certain equipment, and biomedical technicians for repairs amongst other barriers. Additional
issues for patients include poor road infrastructure, financial resources, distance from doctors
or laboratories, and lack of understanding of disease processes.
Haiti, like many low-income countries, has low literacy levels [3] and low health literacy [4].
Most patients are not diagnosed at all, or at advanced stages of chronic illnesses when symptoms
are prevalent, or are not diagnosed according to guidelines as there is little primary care for
screening. In low-income countries with severe resource constraints, innovative methods for
efficient screening and diagnosis are essential for the nearly one billion people worldwide
who will require daily medications for NCDs and their risk factor management by 2030 [5].
POCT has been well validated as comparable to testing in laboratory settings for hemoglo-
bin A1c (HbA1c) [6, 7], creatinine [8], and cholesterol (total, high-density lipoprotein choles-
terol (HDL-C), triglycerides (TGs)) [9, 10]. POCT could be potentially used for screening of
illnesses (for example, how dyslipidemia or diabetes is screened for in the United States). One
can imagine that not having to go to a local laboratory away from a clinic or having instant
results to a patient may increase desire for testing. POCT has been shown to increase the test-
ing of specific diseases when available, for example when rapid HIV tests were made accessible
[11]. An example of monitoring control on treatment would be diabetes. Using HbA1c to
https://www.cambridge.org/core/terms. https://doi.org/10.1017/gheg.2019.6
Downloaded from https://www.cambridge.org/core. IP address: 107.221.181.201, on 06 Nov 2019 at 18:10:54, subject to the Cambridge Core terms of use, available at
monitor a disease state every three months reduces the need for
self-testing of daily blood sugars and can be especially helpful
where resources don’t permit a daily measurement.
The use of community-health workers (CHWs) for manage-
ment of NCDs has been shown to be effective for prevention
[12], diagnosis [13], and management [14, 15] of NCDs [16],
including multi-component interventions [17], and in low-
resource settings [18–20]. Using CHWs is ideal in many resource-
poor settings which lack physicians and other more highly skilled
healthcare providers. For example, women’s cancer awareness
research conducted in Haiti by Innovating Health International
discovered that CHWs are one of the top two most-trusted sources
of health information in the country, above even doctors [21].
We present a model for using POCT to determine disease
prevalence as used in our study of chronic disease in the Haiti
Health Study [22], in rural and urban Haiti. We hope that this
paper provides useful guidance for those attempting to perform
prevalence or screening studies using POCT in resource poor
settings.
Materials and methods
Community engagement
Knowing that local buy-in was of tantamount importance, prior
to initiation of the study existing CHWs announced to local com-
munity leaders (priests, government officials, school principals,
etc.) the study aims and sought their input and acceptance.
These community leaders then relayed this information to their
respective groups and answered any questions about the study.
This was relayed back to the study team and through a back
and forth process, concerns were addressed to help minimize
issues and increase buy-in from the community.
CHW enrolment and training
The CHWs employed for the study were established members of
their communities, but were taken from outside of the study site
so as to limit concern for knowing study participants. In addition
to general CHW training prior to the study, the CHWs received
data collection training over a period of 2 weeks. The initial train-
ing sessions were dedicated to understanding the goals of the
study and general research principles such as privacy, confidenti-
ality, safety, and the importance of obtaining consent. The format
of these sessions was primarily group discussions. Familiarity with
the modified World Health Organization (WHO) Stepwise
Approach to Surveillance (STEPS) survey was established through
role play, with the CHWs acting as both participants and data col-
lectors. The trainers also discussed interview techniques and
examples of how the CHWs could overcome obstacles encoun-
tered when collecting data. Trainers also observed pairs of
CHWs as they completed the survey and provided direct feedback
as needed. The POCT materials were introduced with a basic
overview of their purpose and the diseases they are associated
with. The execution of the POCT was taught using a teach-back
technique. Prior to the completion of the training, all CHWs
completed practice interviews with members in the community
while being observed by the trainers. The selection of the
CHWs to ultimately complete the study was based on the demon-
stration of proficiency in conducting the survey and implement-
ing all of the POCT.
Study design
Using a multi-stage cluster sampling method, six CHWs recruited
more than 2100 participants door-to-door and collected data on
diet, exercise, education, cell phone usage, income, NCD risk fac-
tors, and mental health using a modified WHO Stepwise
Approach to Surveillance (STEPS) survey [23]. Measurements of
height, weight, waist circumference, blood pressure, and POCT
for creatinine, cholesterol, andHbA1c were also collected. POC fin-
gerstick tests for HbA1c, lipids, and creatinine were conducted by
CHWs during the same visit in the Haiti Health Study [22].
Men and women between 25 and 65 years of age, residing in
Rivière Froide, Carrefour and Cabral of Thomonde, Central
Plateau were eligible to participate in the study. Men and women
who were cognitively impaired or women who were pregnant were
excluded. The Institutional Review Board approval was obtained
through the University of Florida College of Medicine and the
Haitian Medical Association National Bioethics Committee.
POCT data collection
CHWs introduced the project to participants, which was generally
well-received. Each of the POCT fingerstick tests was obtained in
a similar manner, starting with proper preparation and cleaning
of the site of sampling with an alcohol swab. Two to three finger-
sticks were required for the three tests. It was too logistically dif-
ficult to only visit households that had fasted that day, especially
since measurements were conducted well into the afternoon, thus
tests were considered random. Initially, each biochemical test was
performed with a single fingerstick to a separate finger, but this
was discovered to be cumbersome to the participants. As a result,
the creatinine test was performed on a second drop of blood from
the same fingerstick after either the HbA1c or cholesterol test was
completed without affecting the results, as per the manufacturer’s
specifications. The decreased burden on the participants led to an
increase in acceptability as per the CHWs, although not statistic-
ally significant. The exposed blood was then drawn from the tip of
the finger, making sure to avoid massaging the finger per guide-
lines from the devices and fed into respective machines.
Devices
Creatinine, as measured via StatSensor Creatinine Express device
(Nova Biomedical, Waltham, MA), was conducted via a drop of
blood fed into an electronic device which would record the
value. HbA1c was obtained using A1c Now+ (Polymer
Technology Systems, Inc., Indiana, US) which required mixing
of a blood sample with a small reagent contained within the
device packet and then eventual deposition of the material onto
a membrane reading chip. The lipid testing was conducted with
the CardioChek Lipid Test (Polymer Technology Systems, Inc.,
Indiana, US) which required blood deposition on a membrane
that was read using a laser detection system; total cholesterol,
TGs, and HDL-C were recorded. All tests were carried out via
manufacturer guidelines. Results obtained from the electronic
testing device were recorded on paper charts and then transferred
to electronic database RedCAP [24]. All sharps utilized during
testing were placed in portable sharp-containers, some as simple
as hard plastic bottles, and disposed of at local health clinics
that had the proper capacity to manage these materials.
Biohazardous materials such as used gloves and gauze were
2 Stuart Malcolm et al.
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disposed in plastic bags that CHWs carried with them during the
day and emptied each evening.
All testing equipment, which included biochemical tests as
well as a weight scale, tape measurer, blood pressure cuff, disposal
equipment, and icepacks were contained in portable backpacks
that the CHWs carried with them during the entirety of the
study. Using this equipment and model, vast distances of land
could be traversed despite the packs weighing slightly over 20
pounds.
Quality control
Quality control was conducted throughout the testing period.
Periodic checks of entered data into the paper forms were com-
pared with recorded values in the cholesterol and creatinine meas-
uring devices to assure fidelity between paper forms and recorded
values. Lipid assays were compared to set a standard assay. HbA1c
was compared to healthy subjects with known values as
validation.
Disease definitions
Diabetes was diagnosed using HbA1c⩾ 6.5% and prediabetes as
defined by HbA1c⩾ 5.7% to <6.4%, as per the American
Diabetes Association. Chronic kidney disease (CKD) was defined
using point of care (POC) creatinine which when combined with
patient’s weight, height, age, and sex is used to calculate glomeru-
lar filtration rates (GFR) (using the Cockroft–Gault calculation)
for each patient. The GFR for stage 1 CKD is ⩾90 ml/min,
stage 2 is 60–89 ml/min, stage 3 is 30–59 ml/min, stage 4 is 15–
29 ml/min, and stage 5 is <15 ml/min. POCT of cholesterol,
which included separate results for total cholesterol, HDL-C
and TGs, and calculated low-density lipoprotein cholesterol
(LDL-C), were used to define dyslipidemias. Elevated total choles-
terol was defined as ⩾240 mg/dL, TG as ⩾150 mg/dL, low HDL-C
as ⩽50 mg/dL in women and ⩽40 mg/dL in men, and elevated
LDL-C as ⩾130 mg/dL. Metabolic syndrome was defined using
modified-Adult Treatment Panel III (ATPIII) criteria which we
defined by three of the following: HbA1c > 5.0%, waist circumfer-
ence ⩾102 cm (men) or ⩾88 cm (women), blood pressure ⩾130/
85 mmHg, TG level ⩾150 mg/dl, HDL-C cholesterol level less
than 40 mg/dl (men) or 50 mg/dl (women). Traditional ATPIII
criteria do not use HbA1c but rather the diagnosis of diabetes
or fasting blood glucose (FBG) ⩾100 mg/dL. We were limited in
being unable to use FBG in our definition due to logistical con-
straints. We chose HbA1c of 5.0% to correlate roughly with
FBG of 100 mg/dL. From prior studies, HbA1c of 5.0% correlates
with a FBG between 96.8 mg/dL [25] and 118.7 mg/dL [26].
Standardized automated wrist blood pressure monitors
(Omron Series 7) were included in our study to measure blood
pressure. Wrist blood pressure measurements were used because
of variability of techniques between users and burden of bringing
multiple-sized blood pressure cuffs with the already large volume
of materials for the study.
Results
Over 2100 participants partook in the study. Between 14.1% and
17.1% were hypertensive, 16.4% to 23.1% were diabetic, and
10.5% to 14.2% had CKD, depending on the region. Metabolic
syndrome was found in 26.3% of the population. Detailed patient
demographics and results by sex and location are presented below
and are adapted from DeGennaro et al. [22].
Of all those tested (N = 2104), 6.1% (N = 129) had a new, pre-
viously unknown diagnosis of hypertension, which means that
39.3% of all hypertensives (N = 328) did not know of their diag-
nosis previously. Of those who screened positive for diabetes
(N = 366), virtually all (93%) were unaware of their diagnosis
(N = 342). Of the total population tested, 2.39% (N = 43) had
high-total cholesterol, and 34.7% (N = 631) had low HDL-C, all
uncontrolled, since only five patients had known high-total chol-
esterol (Tables 1 and 2).
We purchased and used 2500 test strips to perform testing on
the population of just over 2100 individuals. The wastage included
training, error codes, and failure to record the results. The POCT
average costs for this study will be different than what a program
might need to use in a practical setting since the home visits took
over an hour, much more time than a CHW would need for dis-
ease diagnosis or monitoring when used clinically. However, the
equipment and consumables for POCT can be calculated and
extrapolated. Hypertension, body-mass index (BMI), and waist
circumference testing costs were negligible because equipment
was reused. Cholesterol cost was $8.57(USD) per test, HbA1c
cost was $6.52 per test, and creatinine cost was $3.40 per test.
When all the other costs, such as gloves, gauze, and disposal
were included, the total equipment and consumable costs per par-
ticipant was $19.03. The HbA1c machines come bundled with 20
test strips, but the creatinine and cholesterol machines cost $200
and $500 each, respectively. The total cost per participant, or
patient, will drop the more the machines are used over time
and the more the training costs diminish in significance for popu-
lations larger than 2100 people.
Discussion
Our study revealed a high burden of chronic disease in both
urban and rural Haiti. Hypertension was relatively well diagnosed,
which may be attributed to the fact that this is diagnosed with
blood pressure cuffs rather than blood tests. Untreated diabetes
and dyslipidemia can lead to worse morbidity and mortality
and these diseases can be treated successfully with oral medica-
tions. POCT can both be used as an epidemiologic tool but also
a screening test for clinics to ensure proper diagnosis for patients
and thus reduce this burden.
POCT issues
POCT results are limited by their design and their testing envir-
onment. Although well-verified in the literature, there have been
discrepancies noted between tests. Of note, kidney function assays
have been shown to have higher discrepancies at creatinine
<1.4 mg/dL, although they are generally regarded as accurate
[27]. Creatinine measurement in whole blood is challenging as
it can be influenced from different disease states (e.g. hypergly-
cemia, uremia, and treatment medications) that may be difficult
to measure in resource-poor settings. The CardioChek device
used in our study has been well-verified [28].
POC tests are most accurate using the standards for which they
were designed. Most POC tests are designed for primary care
facilities in high-income nations which are often temperature
regulated. For example, each POCT device required certain tem-
perature ranges and are programmed to read error codes when
ambient temperatures are out of range. During summer data
Global Health, Epidemiology and Genomics 3
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collection in Haiti, temperatures consistently exceeded 35°C
which necessitated carrying the POCT device in bags packed
with ice. This was initially quite cumbersome and required trial
and error in the amount of ice to pack and occasionally they
were too cold. To negate this, we used cloth packing to separate
the machines from direct contact with ice. As the day progressed,
the CHWs would empty out the water from melted ice to ensure a
temperature range that was acceptable. Over time, the CHWs
were able to devise a method such to maintain the tests during
the day so that they would all work properly and consistently.
To assure accurate POCT results, we periodically tested each
POCT against subjects with known laboratory confirmed results.
We felt that using a standard while in the field required excess
space and cooling. Alternatively, testing while at our study storage
facility would have been possible but we felt that this didn’t reflect
the temperatures inflicted upon the testing devices while out in
the field.
Potential pitfalls include variation in tested variables. Known
problems associated with testing for HbA1c include hemoglobin
variants that increase variability in results. In our study, even
the high-end prevalence estimates of hemoglobin variants
(13.97%) did not affect the diabetes prevalence in aggregate
Table 1. Socio-demographic characteristics of study participants
Rural (n = 706) Urban (n = 1425) Total (n = 2131)
Variable 42.4 (S.D. 11.7) 39.9 (S.D. 11.7) 40.8 (S.D. 11.8)
Mean age (S.D.) (years) n % n % n %
Sex
Male 258 36.5 571 40.1 829 38.9
Female 448 63.4 854 59.9 1303 61.1
Monthly income (US$)
<25 211 30.1 206 14.7 417 19.8
25–50 89 12.7 144 10.2 233 11.1
51–250 194 27.7 357 25.5 551 26.2
251–500 177 25.2 544 38.8 721 34.5
>500 29 4.1 148 10.5 177 8.4
Education
No formal schooling 559 85.3 715 56.9 1274 66.6
Less than primary school 67 10.2 332 26.4 399 20.8
Primary school 19 2.9 173 13.7 192 10.5
Secondary school 5 0.7 25 1.9 30 1.5
University 5 0.7 11 0.8 16 0.8
Table 2. Results from the Haiti Health Study
Prevalence by sex Prevalence by location
Males Females p valuesa (sex) Urban Rural p valuesb (location)
Hypertension (n = 2104) 11.0 20.2 <0.001 17.1 14.1 0.185
Diabetes (n = 1858) 18.6 20.8 0.001 16.4 23.1 <0.001
CKDc (n = 1980) 8.8 15.8 <0.001 14.2 10.5 0.086
High total cholesterol 0.4 4.0 0.000 2.7 1.8 0.037
High LDL-C (n = 1819) 0.8 4.5 <0.001 3.3 2.1 0.203
Low HDL-C (n = 1819) 35.8 33.6 0.100 32.3 36.2 0.094
High TGs (n = 1819) 5.9 9.0 0.001 7.1 7.8 0.521
Overweight and obese d (n = 2074) 14.3 34.3 <0.001 30.4 18.2 <0.001
Large waist circumference (n = 2074) 4.2 34.3 <0.001 30.4 18.2 <0.001
aComparing male and female prevalence.
bComparing urban and rural prevalence.
cCKD stages 3–5 according to the Cockcroft–Gault formula for the GFR.
dBMI defined as ⩾25 kg/m2.
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[29]. However, a difference of one percent in HbA1c in an indi-
vidual patient with a hemoglobin variant can be significant in a
clinical setting, such as 6.4 mg/dl to 7.4 mg/dl is the difference
between needing treatment for diabetes and not. With creatinine,
there is always a possibility that patients may be dehydrated at the
time of testing, and perhaps this may be more likely for manual
laborers in the field as opposed to when they visit a clinic for
standard laboratory testing. POCT might increase the chances
that patients have eaten more recently; however, recent guidelines
suggest that eating may not have a great impact on lipid panels
[30]. Having proper knowledge of the limitations of testing equip-
ment is important in any epidemiological study.
Survey conditions
Other logistical problems that arose from door-to-door POCT
were the vast distances required for healthcare professionals to
get to rural communities as well as the carrying of equipment
that houses and protects the tests. This required CHWs with a
strong baseline level of physical fitness, especially in the moun-
tainous regions. Although the backpacks had all the appropriate
amount of testing equipment and ice packs, the backpacks were
substantially heavy and work was difficult. Paper surveys for the
study contributed to much of the weight. Additionally, since we
measured BMI, scales were carried to each household and
added significantly to the weight and size of the load that each
CHW had to carry. Through trial and error CHWs were eventu-
ally able to estimate the amount of materials needed through the
day and made data collection easier. The use of motorcycles was
less expensive means to transport CHWs and testing materials up
narrower roads that alleviated some of the fatigue associated with
carrying equipment. The backpacks could be easily worn while
sitting on the back of a motorcycle taxi, ideal for low-income
and remote settings. When motorcycles could go no further,
much of the data collection was done on foot.
One experience noted from our study in Haiti was the cultural
fear of losing too much blood via blood testing, which would
result in ‘weakness’. POCT was thus ideal as it minimized the
amount of the sample needed for adequate testing. Most studies
have indicated that POCT is favored, or at least regarded without
difference to, traditional venipuncture [29]. It also had the added
benefit of decreased need for training in this procedure, transport,
and storage of blood vials.
POCT costs
There is a dearth of POCT used for epidemiological surveys and
screening of NCDs. Our study offers a model for being able to
measure chronic disease in low-income countries. POCT is
thought to be more expensive that central laboratory testing
[29], but central testing often relies on labor costs of nursing
and ancillary staff which may be more expensive and which
may not apply to rural settings that require follow-up after a cer-
tain amount of time. For example, for HbA1c and cholesterol for
the NHS in the UK, it is more cost effective to utilize POC rather
than traditional laboratory methods when considering missed
appointments and other factors in the primary care setting [29].
In establishing effective strategies in low-infrastructure settings,
the initial cost of POCT may be worth the initial investment.
However, more specific analysis for particular settings (cost of
transport, rate of missed clinic appointments, likelihood of
follow-up, etc.) for each community would be required to
establish the exact difference in cost. Considering infrastructure
start-up costs in developing nations, costs may be significantly
less, allowing for easier treatment initiation. Given the higher
per test cost, scale-up to national treatment goals may not depend
on POCT alone, but rural areas are the obvious beneficiaries of
such a strategy.
Because NCDs require accurate lab data to effectively monitor
treatment, the ability to remotely measure these values would be
of incredible use. One could imagine that visiting a healthcare
professional both entailed assessment and discussion of
up-to-date lab tests would be most useful and perhaps engage
patients to improve treatment adherence compared to standard
laboratory testing that may require significantly more waiting
time. For example, monitoring of HbA1c in an urban clinic in
South Africa has shown that through POC HbA1c testing, the
number of diabetes patients achieving optimal glycemic control
increased by 125% and the number with very poor glycemic con-
trol halved [31]. In a study of remote Australian Indigenous com-
munities, POC HbA1c leads to improve the time to follow-up
with the physician and increase the frequency of HbA1c measure-
ments per person over the year when compared to laboratory-
based HbA1c testing. The use of POC HbA1c testing also showed
improved glycemic control over a period of 15 months in this
community [32].
Advantages and limitations of model
Using CHWs for screening and diagnosis of NCDs has several
advantages. In addition to the wide acceptance of POCT and
CHWs used in the house, instant results of POCT offer the
chance for immediate education by CHWs. All participants in
our study received their results on a ‘Know Your Numbers’
card which allowed them to review results, understand normal
and abnormal values, ask questions of the CHWs, and bring
results to their doctor. For future programs, CHWs using
POCT offer the possibility of immediate medication refills for
those with well-controlled disease. CHWs could also call doctors
at a clinic to discuss results and even possibly change medications
in the community as well, although this is currently outside the
scope of practice of CHWs in Haiti. CHWs are the trusted source
of information in Haiti and many developing countries and the
human interaction surrounding POCT may increase service util-
ization [33] and possibly treatment adherence [34], but this
requires further study.
A limitation of the study model is based on the under-
representation of men among our sample: 39.5% of the data
came from men, and 60.5% from women. Since the study was
conducted during the day and at homes, men may have been at
work and thus less likely to have completed the study if they
were selected. This has been cited as a limitation in other surveil-
lance work in Haiti [35]. It is unknown if men are more averse to
POCT. Since the study was cross-sectional, we did not follow up
with participants to see if they sought and were started treatment
once made aware of their diagnosis. Strengths of this study
include the vast distance of an area that is extremely limited by
infrastructure, which we felt was an important nuance that
POCT provides. This is one of the few studies looking at chronic
disease in Haiti. We hope that the design and troubleshooting
experienced in our study may help in further establishment of
other projects that will allow proper definition of prevalence
and potentially screening of chronic diseases worldwide.
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